Summary

Terminal Sterilization Services Market Growth & Trends

The global terminal sterilization services market size is expected to reach USD 24.39 billion by 2030, registering a CAGR of 11.08% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing the number of hospital-acquired infections globally is likely to stimulate the market demand. For instance, as per the Patient Care Link Organization, in the U.S. alone, the CDC has estimated that hospital-acquired infections account for 1.7 million infections & 99,000 HAIs-associated deaths. Terminal sterilization services help in sterilizing instruments used during surgical cases. Thus, with the increase in number of HAIs, hospitals are expected to use terminal sterilizers, thereby, impelling the market during the forecast period.

In addition, the increase in surgical procedures is expected to increase the demand for terminal sterilization services during the forecast period. For instance, as per Jama Network, there were an estimated number of 13,108,567 surgical procedures identified in 2019 in the U.S. Similarly, according to the Australian Institute of Health & Welfare, 754,600 patients were admitted for surgery in the public hospitals. Moreover, as per a similar source, the gastrointestinal endoscopy had the largest growth of 107% in 2018. Endoscope needs to be sterilized after their use, and are sterilized by moist heating. Thus, with the increase in number of endoscopic procedures, the market is expected to impel during the forecast period.

Furthermore, with a decline in population suffering from COVID-19, the earlier postponed elective surgeries are expected to be scheduled in near future, as a result, the risk of HAIs and other infections in anticipated to increase. Additionally, many companies were involved in various strategies such as merger & acquisition, product development, & geographic expansion. For instance, in September 2021, Nelson Labs & Sterigenics Germany GmbH announced opening a laboratory and expanding its sterilization facilities in Wiesbaden, Germany. This was expected to help the company capitalize on the growing demand for sterilization facilities. Thus, due to the aforementioned factors, the terminal sterilization services market is anticipated to grow significantly during the post-COVID period.

Terminal Sterilization Services Market Report Highlights

• The ethylene oxide segment dominated the market with the largest revenue share of 40.99% in 2024. This growth can be attributed to its effectiveness in sterilizing a wide range of heat-sensitive medical devices.

• The hospitals & clinics segment dominated the market in 2024 and is expected to witness the fastest growth over the forecast period. The increasing burden of HAIs is primarily boosting the demand for sterilization in hospitals and other healthcare settings.

• The North America terminal sterilization services market held the largest revenue share of 35.43% in 2024.

• The Asia Pacific terminal sterilization services market is set for significant growth, driven by several key factors such as the presence of numerous local players in countries such as China and Japan, as these companies introduce innovative products tailored to regional needs, increasing competition and accessibility.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Third Party Perspective
1.3.5. Primary research
1.3.6. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights Outlook
Chapter 3. Terminal Sterilization Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Related/ancillary market outlook.
3.2. User Perspective Analysis
3.2.1. Consumer behavior analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing prevalence of HAIS
3.3.1.2. Increasing number of surgical procedures
3.3.1.3. Upsurge in prevalence of chronic diseases
3.3.1.4. Growing geriatric population
3.3.1.5. Rising use of endoscope reprocessors and surgical units
3.3.2. Market restraint analysis
3.3.2.1. Paradigm shift from reusable medical devices to disposable medical devices
3.3.2.2. Safety concerns related to EtO sterilization
3.3.3. Market opportunities analysis
3.3.3.1. Increasing application of terminal sterilization in pharmaceutical and biotechnology industry
3.3.3.2. Rising investments in research & development and technology
3.3.3.3. Reinstatement Of EtO sterilization
3.3.3.4. Availability of alternative solution to EtO sterilization
3.4. Terminal Sterilization Services Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Terminal Sterilization Services Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Terminal Sterilization Services Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
4.5.1. Ethylene Oxide
4.5.1.1. Ethylene oxide market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Irradiation
4.5.2.1. Irradiation market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. X-ray
4.5.2.2.1. X-ray market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Gamma (Co 60)
4.5.2.3.1. Gamma (Co 60) market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.4. E-Beam
4.5.2.4.1. E-Beam market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.5. Others
4.5.2.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Moist Heat Terminal Sterilization
4.5.3.1. Moist heat terminal sterilization market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Terminal Sterilization Services Market: End Use Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. End Use Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Terminal Sterilization Services Market by End Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
5.5.1. Hospitals & Clinics
5.5.1.1. Hospitals & clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Pharma & Nutraceuticals
5.5.2.1. Pharma & nutraceuticals market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Medical Device Manufacturing/Packaging
5.5.3.1. Medical device manufacturing/packaging market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Other Manufacturing Sectors
5.5.4.1. Other manufacturing sectors market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Academic Research Institutes
5.5.5.1. Academic research institutes market estimates and forecast 2018 to 2030 (USD Million)
5.5.6. Others
5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Terminal Sterilization Services Market: Regional Estimates & Trend Analysis by Product, End Use
6.1. Regional market share analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2024
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
6.6. North America
6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
6.6.4. Mexico
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework
6.6.4.4. Reimbursement scenario
6.6.4.5. Mexico market estimates and forecasts, 2018 - 2030
6.7. Europe
6.7.1. Germany
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. Germany market estimates and forecasts, 2018 - 2030
6.7.2. UK
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. UK market estimates and forecasts, 2018 - 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 - 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
6.8. Asia Pacific
6.8.1. China
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. China market estimates and forecasts, 2018 - 2030
6.8.2. Japan
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. Japan market estimates and forecasts, 2018 - 2030
6.8.3. India
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. India market estimates and forecasts, 2018 - 2030
6.8.4. Australia
6.8.4.1. Key country dynamics
6.8.4.2. Competitive scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. Australia market estimates and forecasts, 2018 - 2030
6.8.5. South Korea
6.8.5.1. Key country dynamics
6.8.5.2. Competitive scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. South Korea market estimates and forecasts, 2018 - 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
6.9.2. Argentina
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Argentina market estimates and forecasts, 2018 - 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.4. UAE market estimates and forecasts, 2018 - 2030
6.10.5. Kuwait
6.10.5.1. Key country dynamics
6.10.5.2. Competitive scenario
6.10.5.3. Regulatory framework
6.10.5.4. Reimbursement scenario
6.10.5.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2024
7.3.4. 3M
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. STERIS
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Getinge
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. ASP (Fortive)
7.3.7.1. Financial performance
7.3.7.2. Product benchmarking
7.3.7.3. Strategic initiatives
7.3.8. Belimed, Inc. (Metall Zug Group)
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Sterigenics U.S., LLC - A Sotera Health Company
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Fedegari Autoclavi S.p.A.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Olympus Corporation
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Steelco S.p.A.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives